Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain

Journal of Comparative Neurology

Volumn 441, Issue 2, 2001, Pages 118-133

  Rockland, Kathleen S ^a,b   Knutson, Tina ^b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Astrocytes; Microglia; Oligodendrocytes; Phosphorylation

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN SIZE; CELL COUNT; CELL DIFFERENTIATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME DEFICIENCY; GLIA CELL; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; MOUSE MUTANT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL;

ANIMALS; ANOXIA; BLOTTING, WESTERN; BRAIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NEUROLOGIC MUTANTS; MYELIN SHEATH; NEUROGLIA; OLIGODENDROGLIA; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE;

EID: 0035842081     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.1401     Document Type: Article

References (59)

1. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in me(v)/me(v) mutant mice
2. Passage of cytokines across the blood-brain barrier
3. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate
4. Acute focal ischemia-induced alterations in MAP2 immunostaining: Description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury
5. Interferon gamma gene expression in rat central nervous system glial cells
6. Breed differences in deafferentation-induced neuronal cell death and shrinkage in chick cochlear nucleus
7. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice
8. Motheaten, an immunodeficient mutant of the mouse
9. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
10. Effects of unilateral cochlear removal on anteroventral cochlear nucleus neurons in developing gerbils
11. The Ly-1 B cell lineage
12. Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes
13. Localization of SH-PTP1 to synaptic vesicles: A possible role in neurotransmission
14. Cytokines in neuronal development
15. Microglial tyrosine phosphorylation systems in normal and degenerating brain
16. A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice
17. Functional consequences of the SHP-1 defect in motheaten viable mice: Role of NF-kappa B
18. Suppresive effects of monocytic cells and transforming growth factor-beta on natural killer cell differentiation in autoimmune viable motheaten mutant mice
19. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severly impaired in motheaten and viable motheaten mice
20. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain
21. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats
22. Astrocyte proliferation in the chick auditory brainstem following cochlea removal
23. Tyrosine phosphatase SHP-1 immunoreactivity increases in a subset of astrocytes following deafferentation of the chicken auditory brainstem
24. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase
25. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-γ signalling in neural cells
26. Increased inducible activation of NF-kB and responsive genes in astocytes deficient in protein tyosine phosphatase SHP-1
27. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes
28. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain
29. SHP-1 is involved in neuronal differentiation of P19 embryonic carcinoma cells
30. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase
31. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases
32. Permeability of the blood-brain and blood-spinal cord barriers to interferons
33. Intracerebral injection of interferon-gamma inhibits the astrocyte proliferation following the brain injury in the 6-day-old rat
34. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries
35. Isolation of a src homology 2-containing tyrosine phosphatase
36. Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6)
37. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha
38. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE
39. Foreign and endogenous serum protein extravasation during harmaline tremors or kainic acid seizures in the rat: A comparison
40. Characterization of Mott cell hybridomas from autoimmune viable motheaten mutant mice
41. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases
42. Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase
43. Pleiotropic effects of deleterious alleles at the "motheaten" locus
44. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins
45. Genetically determined murine models of immunodeficiency
46. "Viable motheaten," a new allele at the motheaten locus. I. Pathology
47. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
48. Severe defects in immunity and hematopoiesis caused by SHP-1 protein tyrosine phosphatase deficiency
49. Effect of genetically determined immunodeficiency on epidermal dendritic cell populations in C57BL/6J mice
50. Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene
51. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density
52. Differential effects of Bcl-2 over-expression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice
53. Mild hypothermia prevents ischemic injury in gerbil hippocampus
54. Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field
55. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13
56. Hemopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor b chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis
57. Hematopietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo induced receptor tyrosine phosphorylation: Identification of potential binding sites
58. A mouse model of embolic focal cerebral ischemia